Menu
 

CHANGING THE WAY
THE WORLD BREATHES.

TRY our products Today.

Select a product below to learn more and purchase online.

About

Latest Rhinomed NEWS.

  • RNO SIGNS 12 YEAR LICENSING AGREEMENT WITH USA’S LARGEST MEDICAL CANNABIS OPERATOR

    Rhinomed (ASX:RNO) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC.

    Read More
  • RHINOMED REPORTS STRONG H1 YOY GROWTH (4C REPORT)

    Rhinomed (ASX:RNO) a leader in nasal delivery technology is pleased to report continued year on year revenue growth with quarterly revenues in FY19 Q2 of $618k.

    Read More
  • APPENDIX 4E PRELIMINARY FINAL REPORT

    Rhinomed (ASX:RNO) a leader in nasal respiratory technology, today released the Appendix 4E Preliminary Final Report

    Read More